| Home | News Briefs | U.S. | World | Celeb Buzz | Entertainment | Sports | Business | Health | Sci / Tech | Politics | Weird & Offbeat |
|
November 6, 2008 5:30 p.m. EST
AHN Staff Rockville, MD (AHN) - The U.S. Food and Drug Administration (FDA) has issued an alert that 471,000 mislabeled syringes for diabetics being recalled from Wal-Mart and Sam's Clubs stores pose risk of insulin overdose. The agency warned patients and health care professionals not to use disposable 31-gauge, 1cc ReliOn syringes with Lot Number 813900 as its manufacturer, Tyco Healthcare Group LP (Covidien), recalled the product on Oct. 9, 2008 and Wal-Mart notified buyers to return them in exchange for replacements. The said syringes were sold at Wal-Mart and Sam's Clubs stores from Aug. 1, 2008 to Oct. 8, 2008. The syringes being recalled are for use with U-40 insulin but were packed in boxes of syringes for use with U-100 insulin. The FDA said using the wrong syringes could possibly give diabetics 2.5 times the intended insulin dose, which may lead to hypoglycemia, serious health consequences, and even death.
|
|
|
||
|
|
||
| Home | News Briefs | U.S. | World | Entertainment | Sports | Business | Health | Sci / Tech | Politics | Weird / Offbeat |
© 2009 AHN |
|
|
|
||
| Client Login | Submit News | Privacy Policy | Terms of Use | Contact | Content Services | All Rights Reserved | |